MedTrace Logo

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation

NCT05742178 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2160

Last updated 2025-12-18

No results posted yet for this study

Summary

NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" \[PN\] arm) versus providing culturally and linguistically tailored cancer education only (the "less intensive" \[LI\] arm). The study population will include individuals who are due for breast, cervical, or colorectal cancer screening. All individuals recruited to the study will be provided navigation for unmet social determinants of health (SDH) needs.

Conditions

  • Cancer Screening

Interventions

BEHAVIORAL

Patient Navigation (PN) - More Intensive

The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for cancer screening status and social needs and provide navigational support to cancer screening and social services.

BEHAVIORAL

Educational Materials

Both PN and LI participants will receive tailored educational materials around cancer screening and SDH resources as needed.

BEHAVIORAL

Patient Navigation (PN) - Less Intensive

The PN intervention will be administered by trained, bilingual CHWs: they will screen participants for social needs and provide navigational support to social services.

Sponsors & Collaborators

Principal Investigators

  • Chau Trinh, PhD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742178 on ClinicalTrials.gov